ANNX Q2 2024 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena

ANNXAnnexon, Inc.

$713M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$34M

Net Income

-$30M

EPS (Diluted)

$-0.23

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$406M

Total Liabilities

$45M

Stockholders' Equity

$361M

Cash & Equivalents

$157M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$34M	-$38M	+10.9%
Net Income	-$30M	-$35M	+15.9%